Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. | In this tracker, Fierce Pharma is recording the ...

While Novartis secured the biggest deal of the fourth quarter, a handful of riveting tales emerged from the bottom of the M&A ...

Johnson & Johnson’s $14.6 billion buyout of Intra-Cellular in the first mo | Of the top 10 biopharma M&A deals of 2025, six ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

Check out a month-by-month breakdown of the major events affecting the pharma and medical marketing industries in 2025.

Mankind Pharma navigates transformation challenges while aiming for growth through acquisition synergies and sales force reorganization.

IGC Pharma ( ($IGC) ) has provided an announcement. On December 30, 2025, IGC Pharma, Inc. announced that its Board of Directors approved a change ...

Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) ...

Axonal.AI distinguishes itself from the current wave of generative AI chatbots by positioning itself as an enterprise-native operating layer. While standard LLMs often hallucinate or prioritize ...

Investor focus shifts from momentum to valuation and liquidity amid market churn. Quant Mutual Fund's CIO Sandeep Tandon ...